Abstract:
The global and regional impact of the SARS-CoV-2 pandemic is of great concern. Although the availability of vaccines against SARS-CoV-2 has partially alleviated this concern in some parts of the world, it remains a global public health crisis. Diagnosing gut microbiota in patients after infection with COVID-19. The research was conducted on 120 (54 men and 66 women) patients aged 29 to 70 years and 20 healthy people treated for dysbacteriosis in the gastroenterology department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The composition of intestinal microorganisms in patients with dysbacteriosis is almost the same, but its quantitative ratio differs according to whether or not they have had COVID-19.
